{ "items": [ "\n\n
Dramowski A. et al, (2021), JAC-Antimicrobial Resistance, 3
\n \n \n \n\n \n
\n \n \nDramowski A. et al, (2021), JAC-Antimicrobial Resistance, 3
\n \n \n \n\n \n
\n \n \nWang X. et al, (2021), The Lancet. Global health, 9, e33 - e43
\n \n \n \n\n \n
\n \n \nKnoll MD. et al, (2021), Microorganisms, 9
\n \n \n \n\n \n
\n \n \nLucinde RK. et al, (2021), Vaccine
\n \n \n \n\n \n
\n \n \nUyoga S. et al, (2021), Science (New York, N.Y.), 371, 79 - 82
\n \n \n \n\n \n
\n \n \nUyoga S. et al, (2020), Blood advances, 4, 5942 - 5950
\n \n \n \n\n \n
\n \n \nGilchrist JJ. et al, (2020), BMC Medicine, 18
\n \n \n \n\n \n
\n \n \nMcCollum ED. et al, (2020), Pediatric pulmonology, 55, 3197 - 3208
\n \n \n \n\n \n
\n \n \nHead MG. et al, (2020), The Lancet Global Health, 8, e1295 - e1304
\n \n \n \n\n \n
\n \n \nEbruke BE. et al, (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
\n \n \n \n\n \n
\n \n \nGallagher KE. et al, (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70, 1050 - 1057
\n \n \n \n\n \n
\n \n \nKwambana-Adams BA. et al, (2020), Pneumonia (Nathan Qld.), 12
\n \n \n \n\n \n
\n \n \nNjuguna P. et al, (2019), BMC Medicine, 17
\n \n \n \n\n \n
\n \n \nSalzberg NT. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69, S262 - S273
\n \n \n \n\n \n
\n \n \nUyoga S. et al, (2019), The Lancet. Global health, 7, e1458 - e1466
\n \n \n \n\n \n
\n \n \nMuriuki JM. et al, (2019), Science advances, 5
\n \n \n \n\n \n
\n \n \nKagia N. et al, (2019), Clinical Infectious Diseases, 69, 751 - 759
\n \n \n \n\n \n
\n \n \nPneumonia Etiology Research for Child Health (PERCH) Study Group None., (2019), Lancet (London, England), 394, 757 - 779
\n \n \n \n\n \n
\n \n \nOng'ayo G. et al, (2019), The Lancet. Global health, 7, e961 - e967
\n \n \n \n\n \n
\n \n \n